2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Bacteria and Cancer
Bacteria are single-celled organisms that are extremely small. Although the majority of bacteria are harmless, some can infect people and cause diseases. A few have even been linked to the development of cancer. Apart from inducing cancer by interfering with the host's normal defense mechanisms such as inflammation and antigen recognition, some bacteria have been found to produce tumor proteins as a result of metabolic products, which have direct myogenic or mutagenic effects.
Despite the fact that traditional cancer treatments remain the most prominent, bacterial therapy has demonstrated significant results due to its high specificity, ability to control after ingestion, and presence in several live experiments. Because of its tumor selectivity and large gene packaging capability, bacteria targeting tumors is an ideal strategy to administer therapeutic treatments.
- Bacteria Cancer Therapy (BCT)
- Tumor Proteins
- Stomach Cancer and Role of Bacteria
- Engineered Bacterial Strains
- Cancers Associated with Bacterial Infections
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Rihab Melliti
Aix en Provence General Hospital, FranceSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation